Treating stress prevented new MS brain lesions

 

New Orleans, LA (July 16, 2012) – Research conducted by Jesus Lovera, MD, Assistant Professor of Neurology at LSU Health Sciences Center New Orleans, and colleagues has shown that stress management treatment significantly reduced the formation of new brain lesions in people with multiple sclerosis (MS) over the course of treatment. These lesions are markers of disease activity used to objectively measure disease status. The work is published ahead of print and is now available online in Neurology.

 

"Our research found that 77% of the patients undergoing stress management therapy remained free of lesions while they were in treatment compared to 55% of those in the control group," notes Dr. Jesus Lovera, an LSU Health Sciences Center New Orleans board certified neurologist whose research and practice focus on multiple sclerosis.

 

The research team studied 121 patients with relapsing forms of MS, most of whom are women. They were randomly assigned to receive stress management therapy for MS or were wait-listed while continuing to receive their usual treatment for MS. The therapy group received 16 individual treatment sessions over 24 weeks, and were then followed for an additional 24 weeks.

 

The sessions included teaching problem solving skills, relaxation, increasing positive activities, cognitive restructuring, and enhancement of social support. Participants were able to tailor the treatment to meet their needs using optional treatment modules including communication and assertiveness training, fatigue management, anxiety reduction, pain management, management of cognitive problems, and insomnia treatment.

 

MRIs were performed at the start of the study as well as at weeks 8, 16, 24, 32, 40 and 48. They revealed that while lesions were prevented or reduced during stress therapy, the benefit did not continue beyond treatment. Possible explanations include the need for longer, or possibly indefinite stress management therapy, participants’ inability to sustain coping skills once the support of active treatment ended, or that the experience of a supportive relationship was responsible for the changes.

 

"Stress management clearly improved disease activity in the treatment group – our primary finding – for the duration of therapy," concludes Dr. Lovera, "That finding lays the groundwork for further study to determine how best to continue the benefit."

 

According to the National Institutes of Health which funded the study, multiple sclerosis is an autoimmune disease that affects the brain and spinal cord (the central nervous system.) Caused by damage to the myelin sheath that covers and protects nerve cells, the resulting inflammation slows down or stops signals from the nerves. MS affects women more than men. Symptoms range from loss of balance and problems moving arms and legs to double or loss of vision and trouble chewing or swallowing. There is currently no cure.

 

 

In addition to LSU Health Sciences Center New Orleans, the team included researchers from the Northwestern University Feinberg School of Medicine, Evergreen Hospital Medical Center, the University of California, San Francisco, and the San Francisco VA Medical Center.

 

LSU Health Sciences Center New Orleans educates Louisiana’s health care professionals. The state’s academic health leader, LSUHSC New Orleans consists of a School of Medicine, the state’s only School of Dentistry, Louisiana’s only public School of Public Health, Schools of Allied Health Professions and Graduate Studies, and the only School of Nursing within an academic health center in the State of Louisiana. To learn more, visit http://www.lsuhsc.edu and http://www.twitter.com/LSUHSCHealth

 


 

Louisiana State University Health Sciences Center, 16.07.2012 (tB).

MEDICAL NEWS

Inadequate sequencing of SARS-CoV-2 variants impedes global response to COVID-19
New meta-analysis finds cannabis may be linked to development of…
New guidance on how to diagnosis and manage osteoporosis in…
Starting the day off with chocolate could have unexpected benefits
Better mental health supports for nurses needed, study finds

SCHMERZ PAINCARE

Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…
Jedes vierte Kind wünscht bessere Schmerzbehandlung
Lebensqualität von Patienten in der dauerhaften Schmerztherapie mit Opioiden verbessern

DIABETES

Bundestag berät über DMP Adipositas: DDG begrüßt dies als Teil…
Mit der Smartwatch Insulinbildung steuern
Verbände fordern bessere Ausbildung und Honorierung von Pflegekräften für Menschen…
Minimalinvasive Geräte warnen ungenügend vor Unterzuckerung
Typ-1-Diabetes und Hashimoto-Thyreoiditis treten häufig gemeinsam auf

ERNÄHRUNG

Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen
Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren

ONKOLOGIE

Anti-Myelom-Therapie mit zusätzlich Daratumumab noch effektiver
Positive Ergebnisse beim fortgeschrittenen Prostatakarzinom: Phase-III-Studie zur Radioligandentherapie mit 177Lu-PSMA-617
Lymphom-News vom EHA2021 Virtual. Alle Berichte sind nun online verfügbar!
Deutsch-dänisches Interreg-Projekt: Grenzübergreifende Fortbildungskurse in der onkologischen Pflege
Sotorasib: Neues Medikament macht Lungenkrebs-Patienten Hoffnung

MULTIPLE SKLEROSE

NMOSD-Erkrankungen: Zulassung von Satralizumab zur Behandlung von Jugendlichen und Erwachsenen
Verzögerte Verfügbarkeit von Ofatumumab (Kesimpta®)
Neuer Biomarker bei Multipler Sklerose ermöglicht frühe Risikoeinschätzung und gezielte…
Multiple Sklerose beginnt oft lange vor der Diagnose
Goldstandard für Versorgung bei Multipler Sklerose

PARKINSON

Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…
Gemeinsam gegen Parkinson: bessere Therapie durch multidisziplinäre Versorgung